Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Artemisia annua decaffeinated coffee

A decaffeinated coffee formulation containing Artemisia annua, with potential anti-inflammatory, antioxidant and chemopreventive activities. Artemisia annua contains specific sesquiterpene lactones, flavonoids, coumarins, phenolic acids, tannins, saponins, polyalkenes, phytosterols, fatty acids and proteins. The antioxidant compounds scavenge free radicals and inhibit cell damage due to reactive oxygen species (ROS). This inhibits oxidative stress and may protect against DNA damage.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	A. annua decaffeinated coffee Aa decaffeinated coffee ArtemiCoffee Artemisia annua-blended decaffeinated coffee

Artemisia annua decaffeinated coffee

Search NCI's Drug Dictionary